Recipharm reaches agreement with LobSor Pharmaceuticals
Manufacturing of a proprietary treatment for advanced Parkinson’s disease
09-Sep-2015 -
Recipharm and LobSor Pharmaceuticals announced the formation of a manufacturing agreement for LECIGON™. As part of the agreement, Recipharm will have exclusive manufacturing rights for volumes representing first three years of commercial sales. Recipharm will also support development costs ...
collaborations
Parkinson's disease